Principal Financial Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.79K | Buy |
|
|||||
|
2024
Q4 | $10K | Sell |
|
|||||
|
2024
Q3 | $16.2K | Sell |
|
|||||
|
2024
Q2 | $21.7K | Sell |
|
|||||
|
2024
Q1 | $47.1K | Sell |
|
|||||
|
2023
Q4 | $29.4K | Sell |
|
|||||
|
2023
Q3 | $34.4K | Buy |
|
|||||
|
2023
Q2 | $30.5K | Sell |
|
|||||
|
2023
Q1 | $816K | Sell |
|
|||||
|
2022
Q4 | $2.66M | Buy |
|
|||||
|
2022
Q3 | $3.76M | Buy |
|
|||||
|
2022
Q2 | $4.44M | Sell |
|
|||||
|
2022
Q1 | $6.77M | Sell |
|
|||||
|
2021
Q4 | $17M | Buy |
|
|||||
|
2021
Q3 | $12.1M | Sell |
|
|||||
|
2021
Q2 | $11.6M | Buy |
|
|||||
|
2021
Q1 | $13.3M | Buy |
|
|||||
|
2020
Q4 | $9.66M | Buy |
|
|||||
|
2020
Q3 | $9.41M | Sell |
|
|||||
|
2020
Q2 | $13.5M | Buy |
|
|||||
|
2020
Q1 | $9.94M | Sell |
|
|||||
|
2019
Q4 | $16.7M | Buy |
|
|||||
|
2019
Q3 | $4.96M | Sell |
|
|||||
|
2019
Q2 | $9.94M | Sell |
|
|||||
|
2019
Q1 | $9.74M | Buy |
|
|||||
|
2018
Q4 | $9.47M | Buy |
|
|||||
|
2018
Q3 | $17.4M | Buy |
|
|||||
|
2018
Q2 | $12M | Sell |
|
|||||
|
2018
Q1 | $39M | Sell |
|
|||||
|
2017
Q4 | $84M | Sell |
|
|||||
|
2017
Q3 | $35M | Sell |
|
|||||
|
2017
Q2 | $29.9M | Buy |
|
|||||
|
2017
Q1 | $35.9M | Buy |
|
|||||
|
2016
Q4 | $18.3M | Buy |
|
|||||
|
2016
Q3 | $22.8M | Buy |
|
|||||
|
2016
Q2 | $18.2M | Buy |
|
|||||
|
2016
Q1 | $17.2M | Buy |
|
|||||
|
2015
Q4 | $20.4M | Buy |
|
|||||
|
2015
Q3 | $12.6M | Buy |
|
|||||
|
2015
Q2 | $14M | Buy |
|
|||||
|
2015
Q1 | $3.2M | Buy |
|
|||||
|
2014
Q4 | $4.45M | Sell |
|
|||||
|
2014
Q3 | $3.7M | Buy |
|
|||||
|
2014
Q2 | $3.87M | Sell |
|
|||||
|
2014
Q1 | $3.76M | Buy |
|
|||||
|
2013
Q4 | $289K | Sell |
|
|||||
|
2013
Q3 | $323K | Sell |
|
|||||
|
2013
Q2 | $415K | Buy |
|